Save your place

Sign in to WhoBought

Please try again later.

Crinetics Pharmaceuticals, Inc. (CRNX) institutional ownership

Latest close $83.73 Jul 24, 2026
Market cap$2.6B 52-week range SectorHealthcare
Funds holding · Q1 2026
255
reported CRNX position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
156 buyers · 99 sellers

Crinetics Pharmaceuticals, Inc. (CRNX) price and institutional activity

Dates

Q1 2026

$0 bought by 156 investors
Bellevue Group AGT. Rowe Price Investment Management, Inc. +154 more
$0 sold by 99 investors
Point72 Asset Management, L.P.Paradigm Biocapital Advisors LP +97 more
Bought Sold Totals per quarter; hover a bar for the names.

Crinetics Pharmaceuticals, Inc. (CRNX) institutional activity · 255

Investor Type Est. change Change Δ Own Date
Bellevue Group AG · Added
Change +3.3M Date Q1 2026
Bellevue Group AG Added· Q1 2026 +3.3M Q1 2026
Point72 Asset Management, L.P. · Exited
Change −2.3M Δ Own −100.0% Date Q1 2026
Point72 Asset Management, L.P. Exited· Q1 2026 −2.3M −100.0% Q1 2026
Paradigm Biocapital Advisors LP · Exited
Change −2.2M Δ Own −100.0% Date Q1 2026
Paradigm Biocapital Advisors LP Exited· Q1 2026 −2.2M −100.0% Q1 2026
T. Rowe Price Investment Management, Inc. · Added
Change +1.9M Date Q1 2026
T. Rowe Price Investment Management, Inc. Added· Q1 2026 +1.9M Q1 2026
FMR LLC · Added
Change +1.5M Δ Own +10.3% Date Q1 2026
FMR LLC Added· Q1 2026 +1.5M +10.3% Q1 2026
Farallon Capital Management LLC · Added
Change +1.4M Δ Own +20.3% Date Q1 2026
Farallon Capital Management LLC Added· Q1 2026 +1.4M +20.3% Q1 2026
Suvretta Capital Management, LLC · New
Change +1.0M Date Q1 2026
Suvretta Capital Management, LLC New· Q1 2026 +1.0M Q1 2026
Vanguard · Added
Change +1.0M Date Q1 2026
Vanguard Added· Q1 2026 +1.0M Q1 2026
Adar1 Capital Management, LLC · Added
Change +830K Date Q1 2026
Adar1 Capital Management, LLC Added· Q1 2026 +830K Q1 2026
Baker Bros. Advisors LP · Added
Change +703K Date Q1 2026
Baker Bros. Advisors LP Added· Q1 2026 +703K Q1 2026
Marshall Wace, LLP · New
Change +684K Date Q1 2026
Marshall Wace, LLP New· Q1 2026 +684K Q1 2026
BlackRock · Added
Change +490K Date Q1 2026
BlackRock Added· Q1 2026 +490K Q1 2026
Siren, L.L.C. · Added
Change +396K Date Q1 2026
Siren, L.L.C. Added· Q1 2026 +396K Q1 2026
BNP Paribas Asset Management Holding S.A. · Added
Change +389K Date Q1 2026
BNP Paribas Asset Management Holding S.A. Added· Q1 2026 +389K Q1 2026
Jennison Associates LLC · Reduced
Change −377K Date Q1 2026
Jennison Associates LLC Reduced· Q1 2026 −377K Q1 2026
Data through Q1 2026 · filed Jun 3, 2026
15 of 255

Famous investor activity in Crinetics Pharmaceuticals, Inc. (CRNX)

Crinetics Pharmaceuticals, Inc. (CRNX) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Vivaldi Coelho Rogerio · Director Sell −$120K
Price $40.00 Qty −3K Owned 19K ΔOwn −13.5% Trade date Jul 2, 2026 Filed date Jul 7, 2026
Vivaldi Coelho Rogerio Director Sell $40.00 −3K −$120K 19K −13.5% Jul 2, 2026 Jul 7, 2026
Deardorf Caren · Director 2 operations 16K
Owned 10K Trade date Jun 18, 2026 Filed date Jun 22, 2026
Deardorf Caren Director 2 operations 16K 10K Jun 18, 2026 Jun 22, 2026
Fust Matthew K. · Director 2 operations 16K
Owned 10K Trade date Jun 18, 2026 Filed date Jun 22, 2026
Fust Matthew K. Director 2 operations 16K 10K Jun 18, 2026 Jun 22, 2026
Nichols Weston · Director 2 operations 16K
Owned 10K Trade date Jun 18, 2026 Filed date Jun 22, 2026
Nichols Weston Director 2 operations 16K 10K Jun 18, 2026 Jun 22, 2026
Vivaldi Coelho Rogerio · Director 2 operations 16K
Owned 10K Trade date Jun 18, 2026 Filed date Jun 22, 2026
Vivaldi Coelho Rogerio Director 2 operations 16K 10K Jun 18, 2026 Jun 22, 2026
Bedrosian Camille L. · Director 2 operations 16K
Owned 10K Trade date Jun 18, 2026 Filed date Jun 22, 2026
Bedrosian Camille L. Director 2 operations 16K 10K Jun 18, 2026 Jun 22, 2026
Wierenga Wendell · Director 2 operations 16K
Owned 10K Trade date Jun 18, 2026 Filed date Jun 22, 2026
Wierenga Wendell Director 2 operations 16K 10K Jun 18, 2026 Jun 22, 2026
Okey Stephanie · Director 2 operations 16K
Owned 10K Trade date Jun 18, 2026 Filed date Jun 22, 2026
Okey Stephanie Director 2 operations 16K 10K Jun 18, 2026 Jun 22, 2026
Okey Stephanie · Director 2 operations −$246K
Price $35.62–$36.22 Qty −7K Owned 6K Trade date Jun 17, 2026 Filed date Jun 18, 2026
Okey Stephanie Director 2 operations $35.62–$36.22 −7K −$246K 6K Jun 17, 2026 Jun 18, 2026
Struthers Richard Scott · Director 14 operations 0
Owned 111K Trade date May 29, 2026 Filed date Jun 2, 2026
Struthers Richard Scott Director 14 operations 0 111K May 29, 2026 Jun 2, 2026
Knight Jeff E. · Officer Sell −$3.4M
Price $40.10 Qty −85K Owned 105K Trade date Apr 8, 2026 Filed date Apr 10, 2026
Knight Jeff E. Officer Sell $40.10 −85K −$3.4M 105K Apr 8, 2026 Apr 10, 2026
Knight Jeff E. · Officer 6 operations 0
Price $19.64–$23.98 Owned 66K Trade date Apr 8, 2026 Filed date Apr 10, 2026
Knight Jeff E. Officer 6 operations $19.64–$23.98 0 66K Apr 8, 2026 Apr 10, 2026
Knight Jeff E. · Officer 2 operations −$370K
Price $37.11–$37.77 Qty −10K Owned 116K Trade date Mar 16, 2026 Filed date Mar 18, 2026
Knight Jeff E. Officer 2 operations $37.11–$37.77 −10K −$370K 116K Mar 16, 2026 Mar 18, 2026
Betz Stephen F. · Officer 2 operations −$397K
Price $37.11–$37.77 Qty −11K Owned 137K Trade date Mar 16, 2026 Filed date Mar 18, 2026
Betz Stephen F. Officer 2 operations $37.11–$37.77 −11K −$397K 137K Mar 16, 2026 Mar 18, 2026
Struthers Richard Scott · Director, Officer 2 operations −$822K
Price $37.11–$37.77 Qty −22K Owned 405K Trade date Mar 16, 2026 Filed date Mar 18, 2026
Struthers Richard Scott Director, Officer 2 operations $37.11–$37.77 −22K −$822K 405K Mar 16, 2026 Mar 18, 2026
15 of 41
15 of 41 Sign in to continue to older insider transactions.

Crinetics Pharmaceuticals, Inc. (CRNX) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
BlackRock Inc. 5.3M
% of shares outstanding 8.0% Filing date Jan 25, 2024
BlackRock Inc. 5.3M 8.0% Jan 25, 2024
Vanguard Group Inc 6.3M
% of shares outstanding 7.8% Filing date Nov 12, 2024
Vanguard Group Inc 6.3M 7.8% Nov 12, 2024
Wellington Management Group LLP 8.2M
% of shares outstanding 7.8% Filing date May 15, 2026
Wellington Management Group LLP 8.2M 7.8% May 15, 2026
Driehaus Capital Management LLC 5.0M
% of shares outstanding 7.5% Filing date Feb 14, 2024
Driehaus Capital Management LLC 5.0M 7.5% Feb 14, 2024
T. Rowe Price Associates 4.9M
% of shares outstanding 6.2% Filing date Nov 14, 2024
T. Rowe Price Associates 4.9M 6.2% Nov 14, 2024
Driehaus Capital Management LLC 6.4M
% of shares outstanding 6.1% Filing date May 15, 2026
Driehaus Capital Management LLC 6.4M 6.1% May 15, 2026
FMR LLC 4.0M
% of shares outstanding 6.1% Filing date Feb 9, 2024
FMR LLC 4.0M 6.1% Feb 9, 2024
Wellington Management Group LLP 4.5M
% of shares outstanding 5.6% Filing date Nov 8, 2024
Wellington Management Group LLP 4.5M 5.6% Nov 8, 2024
8 of 17

Crinetics Pharmaceuticals, Inc. (CRNX) ownership FAQ

Who owns CRNX?

255 reporting institutions disclosed CRNX position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.